UNSPSC 51302304: Brolaconazole

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6CHG505391. European Medicines Agency schedules Brolaconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05902MIG. Brolaconazole generally arises in the molecular formula C17H15BRN2.

UNSPSC 51302304 Brolaconazole (Commodity) shows minimal recent state and local procurement activity aligned with its nominal scope. The code's abstract definition targets a specific fungicide active ingredient, but the single recent opportunity posted under it—the City of Tampa Fire Rescue Department's ITB 25-P-00157 for Medical Aid Supplies—covers a broad array of first aid and emergency medical consumables including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, and emergency blankets, with no reference to brolaconazole or fungicidal compounds. The mismatch suggests either miscoding by the issuing body or that the code is rarely used for its intended purpose in state and local procurement.

The City of Tampa's April 2026 posting, targeting a $100,000 annual budget with potential two-year renewals, is the sole recent opportunity in the source. The solicitation includes City-certified Small Local Business Enterprise (SLBE) and Underutilized Woman and Minority Owned Business Enterprise (U-WMBE) set-asides with bid discounts capped at $10,000 for SLBEs and $20,000 for U-WMBEs, and requires all medications to meet a nine-month minimum expiration date from acceptance. Bidders must submit documentation including business licenses, minority business status certifications, conflict of interest disclosures, and criminal history screening practices. No other states or jurisdictions appear in the recent-opportunities block. If brolaconazole procurement exists in state and local markets, it is not surfacing in current visible solicitations.